| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 04-12-2025 | ||||||
| NAV | ₹17.42(R) | -0.21% | ₹17.89(D) | -0.21% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 5.07% | -% | -% | -% | -% |
| Direct | 6.32% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.12% | 21.61% | 14.04% | 15.04% | 7.75% | |
| SIP (XIRR) | Regular | 10.64% | -% | -% | -% | -% |
| Direct | 11.96% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/06/2025 | 1682 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | - | ||||
| Sbi Healthcare Opportunities Fund | - | ||||
NAV Date: 04-12-2025
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 17.42 |
-0.0400
|
-0.2100%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 17.42 |
-0.0400
|
-0.2100%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 17.89 |
-0.0400
|
-0.2100%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 17.89 |
-0.0400
|
-0.2100%
|
Review Date: 04-12-2025
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.26 | 2.81 |
-1.01
|
-1.79 | -0.09 | 2 | 12 | Very Good |
| 3M Return % | 1.04 | 4.79 |
0.09
|
-1.09 | 1.13 | 2 | 13 | Very Good |
| 6M Return % | 7.30 | 7.96 |
4.26
|
-1.94 | 8.01 | 2 | 13 | Very Good |
| 1Y Return % | 5.07 | 3.12 |
-0.50
|
-7.34 | 5.07 | 1 | 13 | Very Good |
| 1Y SIP Return % | 10.64 |
3.34
|
-25.71 | 10.70 | 2 | 13 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -0.17 | 2.81 | -0.91 | -1.66 | -0.01 | 2 | 12 | Very Good |
| 3M Return % | 1.34 | 4.79 | 0.41 | -0.84 | 1.47 | 2 | 13 | Very Good |
| 6M Return % | 7.94 | 7.96 | 4.93 | -1.15 | 8.94 | 2 | 13 | Very Good |
| 1Y Return % | 6.32 | 3.12 | 0.79 | -5.81 | 6.47 | 2 | 13 | Very Good |
| 1Y SIP Return % | 11.96 | 4.69 | -24.55 | 12.63 | 2 | 13 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 04-12-2025 | 17.423 | 17.887 |
| 03-12-2025 | 17.374 | 17.835 |
| 02-12-2025 | 17.46 | 17.924 |
| 01-12-2025 | 17.488 | 17.951 |
| 28-11-2025 | 17.539 | 18.002 |
| 27-11-2025 | 17.465 | 17.925 |
| 26-11-2025 | 17.489 | 17.95 |
| 25-11-2025 | 17.36 | 17.817 |
| 24-11-2025 | 17.35 | 17.806 |
| 21-11-2025 | 17.348 | 17.802 |
| 20-11-2025 | 17.453 | 17.909 |
| 19-11-2025 | 17.416 | 17.871 |
| 18-11-2025 | 17.426 | 17.88 |
| 17-11-2025 | 17.572 | 18.03 |
| 14-11-2025 | 17.546 | 18.001 |
| 13-11-2025 | 17.401 | 17.852 |
| 12-11-2025 | 17.394 | 17.844 |
| 11-11-2025 | 17.268 | 17.714 |
| 10-11-2025 | 17.386 | 17.835 |
| 07-11-2025 | 17.318 | 17.763 |
| 06-11-2025 | 17.346 | 17.792 |
| 04-11-2025 | 17.469 | 17.917 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.